Inhibition of TREM-1 ameliorates Lipopolysaccharide-induced depressive-like behaviors by alleviating neuroinflammation in the PFC via PI3K/Akt signaling pathway
Behavioural Brain Research · 2023
DOI: 10.1016/j.bbr.2023.114464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2023. Verfasst von Anhui Fu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Triggering Receptor Expressed on Myeloid Cells-1. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Neuroinflammation is closely related to depression and is a key pathophysiological process of depression. Triggering receptor expressed on myeloid cells 1 (TREM-1) has been proven to exert proinflammatory effects in various diseases. However, the role of TREM-1 in depression has not been elucidated. Thus, we hypothesized that TREM-1 inhibition might have protective effects in depression. Here, lipopolysaccharide (LPS) was used to induce depressive-like behaviors in mice, LP17 was treated to inhibit TREM-1, and LY294002 was administrated to inhibit phosphatidylinositol 3-kinase (PI3K) which is one of the downstream of TREM-1. Physical and neurobehavioral tests, Western blot analysis, and immunofluorescence staining were performed in this study. We found that LPS caused significant depressive-like behaviors in mice, including body weight decline, anodynia (sucrose preference decrease), lack of locomotor activity, and desperation in tail suspension test (TST) and forced swimming test (FST). Next, we revealed that TREM-1 was expressed on microglia, neurons, and astrocytes in the prefrontal cortex (PFC) after LPS administration. TREM-1 inhibition by LP17 suppressed the expression of TREM-1 in the PFC. In addition, LP17 could alleviate neuroinflammation and microglial activation in the PFC. Meanwhile, LP17 could prevent damage of LPS to neuronal primary cilia and neuronal activity. Finally, we revealed that PI3K/Akt might exert crucial role in the protective effects of TREM-1 inhibition to depressive-like behaviors induced by LPS. Taken together, TREM-1 inhibition by LP17 could alleviate depressive-like behaviors induced by LPS by mitigating neuroinflammation in the PFC via PI3K/Akt signaling pathway. Finally, we demonstrated that TREM-1 might be a promising therapeutic target for treatment of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China.
- Department of Ultrasound, Chonggang general hospital, Chongqing, China. Electronic address: luoq125@163.com.
Zitieren
APA
Fu, A., Qiao, F., Feng, H., & Luo, Q. (2023). Inhibition of TREM-1 ameliorates Lipopolysaccharide-induced depressive-like behaviors by alleviating neuroinflammation in the PFC via PI3K/Akt signaling pathway. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114464
Vancouver
Fu A, Qiao F, Feng H, Luo Q. Inhibition of TREM-1 ameliorates Lipopolysaccharide-induced depressive-like behaviors by alleviating neuroinflammation in the PFC via PI3K/Akt signaling pathway. Behavioural Brain Research. 2023. doi:10.1016/j.bbr.2023.114464
BibTeX
@article{Fu2023,
author = {Fu, Anhui and Qiao, Fei and Feng, Hao and Luo, Qing},
title = {Inhibition of TREM-1 ameliorates Lipopolysaccharide-induced depressive-like behaviors by alleviating neuroinflammation in the PFC via PI3K/Akt signaling pathway},
journal = {Behavioural Brain Research},
year = {2023},
doi = {10.1016/j.bbr.2023.114464}
}
EUVIMED